Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.
Po-Lun
PL
Wu
Hsien-Yuan
HY
Lane
Kuan-Pin
KP
Su
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D018450:Disease Progression; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced / Q000175:diagnosis; D006949:Hyperlipidemias / Q000139:chemically induced / Q000175:diagnosis; D008297:Male; D000077152:Olanzapine; D018967:Risperidone / Q000627:therapeutic use*; D012563:Schizophrenia, Paranoid / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D018967:Risperidone; D000077152:Olanzapine